San Jose, CA, United States of America

Hrair Kirakossian

This inventor holds 24 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent, primarily in Biomarker Detection. Top assignees: Monogram Biosciences, Inc., Dade Behring Marburg Gmbh, Becton Dickinson and Company Limited. Active years: 1990-2022.


% Patents Active = 83.3

 

 

Average Co-Inventor Count = 3.3

ph-index = 16

Forward Citations = 719(Granted Patents)


Location History:

  • San Jos, CA (US) (2007)
  • San Jose, CA (US) (1990 - 2022)

Company Filing History:


Years Active: 1990-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Blood Separation Device
Protein Analysis
Cell Detection
Cell Culture
Bioreactor
Luminescence Assays
Photoactivation
Multiplex Analysis
Biomarker Detection
Particle Detection
Heterogeneous Assays
Molecular Tags
24 patents (USPTO):Explore Patents

Title: Innovations of Hrair Kirakossian: A Spotlight on His Patents and Career Achievements

Introduction

Hrair Kirakossian is an accomplished inventor based in San Jose, California, known for his impressive portfolio of 24 patents. His contributions to the field of biomedical engineering have garnered attention for their innovative approaches to blood analysis and separation.

Latest Patents

Among his most notable inventions is the "Small Volume Self-Metered Blood Separation Device." This invention presents devices and methods that facilitate low-cost and convenient separation of plasma from whole blood. The design includes an integrated collection of channels and chambers within a body that allows for the acquisition of blood samples via capillary action, followed by centrifugal separation of cells from plasma. Users can easily dispense purified plasma by pinching a bellows chamber, which forces air into plasma-holding channels to expel a predetermined volume of plasma.

Another significant patent by Kirakossian is centered around "Methods and Compositions for Analyzing Proteins." This invention details compositions, kits, and methods designed for determining one or more target polypeptides in a sample, particularly when those polypeptides have undergone post-translational modifications. The innovative compositions feature a first reagent with a cleavage-inducing moiety and a first binding agent for a binding site that highlights a post-translational modification of a target polypeptide.

Career Highlights

Throughout his career, Hrair Kirakossian has contributed his expertise to several reputable companies, including Monogram Biosciences, Inc. and Dade Behring Marburg GmbH. His work in these organizations has enabled him to push the boundaries of biomedical innovation and develop cutting-edge technologies in the field.

Collaborations

Kirakossian has also collaborated with talented individuals such as Edwin F. Ullman and John S. Pease. These partnerships have fostered the exchange of ideas and expertise, leading to the advancement of various projects and products in the medical field.

Conclusion

Hrair Kirakossian's innovative spirit and dedication to improving biomedical technology through his patents and collaborations make him a noteworthy figure in the field. His work continues to impact the way blood analysis and separation are conducted, paving the way for future advancements in medical technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…